# OPRK1

## Overview
The OPRK1 gene encodes the kappa opioid receptor (KOR), a G protein-coupled receptor (GPCR) that plays a crucial role in the modulation of pain, mood, and stress responses. As a transmembrane receptor, KOR is involved in the regulation of neurotransmitter release, particularly dopamine, within the brain's reward system, influencing behaviors related to addiction and mood regulation (Edenberg2008A). The receptor is predominantly expressed in various brain regions, including the ventral forebrain, hypothalamus, thalamus, and midbrain, where it mediates the physiological actions of endogenous ligands such as dynorphin (Arvidsson1995The). Beyond its central nervous system functions, KOR is also implicated in reproductive processes, with expression observed in human oocytes (Agirregoitia2012Expression). Genetic variations in OPRK1 have been associated with psychiatric and substance use disorders, underscoring its clinical significance in addiction and mental health (Levran2012The; Nielsen2013The).

## Structure
The OPRK1 gene encodes the kappa opioid receptor, a G protein-coupled receptor (GPCR) involved in modulating pain and mood. The primary structure of the kappa opioid receptor consists of a sequence of amino acids that form the receptor protein. The secondary structure is characterized by the presence of alpha helices, which are typical of GPCRs. These helices contribute to the receptor's ability to span the cell membrane multiple times, forming a helical bundle that is crucial for its function.

The tertiary structure involves the folding of these alpha helices into a specific three-dimensional conformation, allowing the receptor to interact with various ligands and G proteins. While the quaternary structure details are less defined, it is suggested that the kappa opioid receptor may form dimers, which could influence its signaling properties.

Post-translational modifications such as phosphorylation and glycosylation are common in the kappa opioid receptor and play significant roles in modulating its function and signaling pathways. These modifications can affect receptor activity, localization, and interactions with other proteins.

Splice variants of the OPRK1 gene can lead to different isoforms of the receptor, each with distinct functional properties. One such variant, KOR1A, includes a 42-nucleotide deletion in exon 3, which may alter its functional characteristics (Yuferov2004Redefinition).

## Function
The OPRK1 gene encodes the kappa opioid receptor (KOR), a G-protein-coupled receptor involved in various physiological processes. In healthy human cells, KOR plays a significant role in modulating neurotransmitter release, particularly dopamine, in the brain's reward system. Activation of KOR can lead to reduced dopamine release in the nucleus accumbens, which is associated with aversive states and can influence behaviors related to addiction and mood regulation (Edenberg2008A).

KOR is primarily located in the postsynaptic membranes of neurons, with significant presence in brain regions such as the ventral forebrain, hypothalamus, thalamus, and midbrain. This distribution suggests its involvement in mediating the physiological actions of endogenous ligands like dynorphin, which are crucial for modulating pain perception and stress responses (Arvidsson1995The).

The receptor is also implicated in reproductive processes, as it is expressed in human oocytes and shows changes in localization during different stages of meiosis. This suggests a potential role in oocyte maturation (Agirregoitia2012Expression). Overall, KOR's activity in the central nervous system and its interaction with endogenous opioids highlight its importance in regulating pain, mood, and stress responses.

## Clinical Significance
Mutations and alterations in the OPRK1 gene, which encodes the kappa opioid receptor, have been linked to various psychiatric and substance use disorders. The gene is associated with addiction, particularly opioid and alcohol dependence. Specific single nucleotide polymorphisms (SNPs) such as rs1051660 and rs6473797 have been implicated in opioid and alcohol dependence, with rs1051660 showing associations with opioid dependence across different populations (Levran2012The; Nielsen2013The). The 36G>T SNP has been associated with heroin addiction, with studies indicating a higher frequency of the T allele in heroin-dependent individuals (Demircan2023The; Gerra2007Human).

Alterations in OPRK1 expression levels, such as those caused by an 830 bp indel in the promoter region, have been linked to alcohol dependence. This indel reduces transcriptional activity, potentially increasing the risk of alcoholism (Edenberg2008A). The kappa opioid receptor's role in modulating dopaminergic tone and stress responses suggests that genetic variations in OPRK1 may influence vulnerability to psychiatric disorders like schizophrenia and mood disorders (Butelman2012κ-opioid; Tejeda2011The). These findings highlight the clinical significance of OPRK1 in addiction and psychiatric conditions.

## Interactions
OPRK1, or opioid receptor kappa 1, is known to engage in various protein interactions that influence its function in modulating pain perception, mood, and consciousness. It interacts with G proteins, which are crucial for initiating intracellular signaling cascades upon receptor activation. These interactions are essential for the receptor's role in modulating pathways such as the MAPK/ERK pathway, which is involved in cell signaling processes related to growth and differentiation.

In addition to G proteins, OPRK1 interacts with arrestins, which play a significant role in receptor desensitization and internalization. Arrestins can bind to the receptor following its activation and phosphorylation, leading to the termination of G protein signaling and the initiation of alternative signaling pathways. This interaction is critical for regulating the receptor's responsiveness to stimuli and maintaining cellular homeostasis.

The interactions of OPRK1 with these proteins can lead to the formation of multiprotein complexes that modulate its signaling capabilities. These complexes can influence the receptor's ability to undergo desensitization and internalization, thereby affecting its overall signaling output and physiological effects. Through these interactions, OPRK1 plays a pivotal role in the modulation of various physiological processes.


## References


[1. (Demircan2023The) Gunnur Demircan, Tuğçe Toker Uğurlu, Gülizar Zengin, Ata Onur Kepenek, Selim Can Berk, Damla Saygin, Idea Nehir Ozliman, Figen Ateşci, and Demet Akın. The frequency of oprk1 g36t and oprm1 a118g opioid receptor gene polymorphisms in heroin-dependent individuals and non-dependent healthy subjects in turkey. Journal of Clinical Psychiatry, 26(3):163–169, 2023. URL: http://dx.doi.org/10.5505/kpd.2023.73693, doi:10.5505/kpd.2023.73693. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.5505/kpd.2023.73693)

[2. (Nielsen2013The) David A. Nielsen, Sara C. Hamon, and Thomas R. Kosten. The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatric Genetics, 23(6):225–232, December 2013. URL: http://dx.doi.org/10.1097/ypg.0000000000000008, doi:10.1097/ypg.0000000000000008. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/ypg.0000000000000008)

[3. (Edenberg2008A) H. J. Edenberg, J. Wang, H. Tian, S. Pochareddy, X. Xuei, L. Wetherill, A. Goate, T. Hinrichs, S. Kuperman, J. I. Nurnberger, M. Schuckit, J. A. Tischfield, and T. Foroud. A regulatory variation in oprk1, the gene encoding the -opioid receptor, is associated with alcohol dependence. Human Molecular Genetics, 17(12):1783–1789, March 2008. URL: http://dx.doi.org/10.1093/hmg/ddn068, doi:10.1093/hmg/ddn068. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddn068)

[4. (Gerra2007Human) G. Gerra, C. Leonardi, E. Cortese, A. D’Amore, A. Lucchini, G. Strepparola, G. Serio, G. Farina, F. Magnelli, A. Zaimovic, A. Mancini, M. Turci, M. Manfredini, and C. Donnini. Human kappa opioid receptor gene (oprk1) polymorphism is associated with opiate addiction. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(6):771–775, August 2007. URL: http://dx.doi.org/10.1002/ajmg.b.30510, doi:10.1002/ajmg.b.30510. This article has 61 citations.](https://doi.org/10.1002/ajmg.b.30510)

[5. (Butelman2012κ-opioid) Eduardo R. Butelman, Vadim Yuferov, and Mary Jeanne Kreek. Κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends in Neurosciences, 35(10):587–596, October 2012. URL: http://dx.doi.org/10.1016/j.tins.2012.05.005, doi:10.1016/j.tins.2012.05.005. This article has 152 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.tins.2012.05.005)

[6. (Tejeda2011The) H. A. Tejeda, T. S. Shippenberg, and R. Henriksson. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cellular and Molecular Life Sciences, 69(6):857–896, October 2011. URL: http://dx.doi.org/10.1007/s00018-011-0844-x, doi:10.1007/s00018-011-0844-x. This article has 133 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-011-0844-x)

[7. (Yuferov2004Redefinition) Vadim Yuferov, David Fussell, K Steven LaForge, David A Nielsen, Derek Gordon, Ann Ho, Suzanne M Leal, Jurg Ott, and Mary Jeanne Kreek. Redefinition of the human kappa opioid receptor gene (oprk1) structure and association of haplotypes with opiate addiction. Pharmacogenetics, 14(12):793–804, December 2004. URL: http://dx.doi.org/10.1097/00008571-200412000-00002, doi:10.1097/00008571-200412000-00002. This article has 90 citations.](https://doi.org/10.1097/00008571-200412000-00002)

[8. (Levran2012The) Orna Levran, Vadim Yuferov, and Mary Jeanne Kreek. The genetics of the opioid system and specific drug addictions. Human Genetics, 131(6):823–842, May 2012. URL: http://dx.doi.org/10.1007/s00439-012-1172-4, doi:10.1007/s00439-012-1172-4. This article has 88 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-012-1172-4)

[9. (Agirregoitia2012Expression) Ekaitz Agirregoitia, Laura Peralta, Rosario Mendoza, Antonia Expósito, Elena Díaz Ereño, Roberto Matorras, and Naiara Agirregoitia. Expression and localization of opioid receptors during the maturation of human oocytes. Reproductive BioMedicine Online, 24(5):550–557, May 2012. URL: http://dx.doi.org/10.1016/j.rbmo.2012.02.007, doi:10.1016/j.rbmo.2012.02.007. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.rbmo.2012.02.007)

[10. (Arvidsson1995The) U Arvidsson, M Riedl, S Chakrabarti, L Vulchanova, J H Lee, A H Nakano, X Lin, H H Loh, P Y Law, and M W Wessendorf. The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proceedings of the National Academy of Sciences, 92(11):5062–5066, May 1995. URL: http://dx.doi.org/10.1073/pnas.92.11.5062, doi:10.1073/pnas.92.11.5062. This article has 130 citations.](https://doi.org/10.1073/pnas.92.11.5062)